D&D Pharmatech Announces First Patient Dosed in Phase 1 Clinical Trial of DD01 in Obese Patients with Diabetes and NAFLD
DD01 is a long-acting dual agonist of GLP-1 and glucagon receptors, which resulted in weight loss, improved metabolic control and...

Bayern’s 2-0 win in Madrid is a depth story, not just a Kane story
United’s Roma comeback buys Carrick time, not answers
United’s late Cunha heroics beat Roma, but the red card explains the doubt
Inter’s clinical 3-0 at De Kuip turns Rotterdam trip into statement
Mbappé hits 100 UCL appearances as Saliba returns: Champions League matchday 4 
















